Cholinesterase inhibitors prevent the breakdown ... chemical are low in the brains of people with AD. The use of these drugs can partially correct the deficit. The three ChEIs now available ...

Lewy body disease (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson’s disease with or without dementia, is ...

Dementia, affecting millions globally, is a syndrome characterized by cognitive decline, impacting memory, thinking, and ...

74-year-old Jennifer Brown, who is currently participating in the NorAD clinical trial of extended-release guanfacine as an add-on to standard cholinesterase drugs for Alzheimer's, said trial ...

intoxication or adverse effect of drugs; withdrawal of anticholinergics, amantadine and benzodiazepines; reduction of dopaminergic therapy; and the addition of cholinesterase inhibitors (donepezil ...

One thing that makes several of them stand out is that drug use from their recent or distant past is not a major issue, is overshadowed by other issues or is not currently raising a furor in an ...

Medications such as Cholinesterase Inhibitors (e.g., donepezil), Memantine, Lecanemab and Donanemab (5 ). Therapies like occupational therapy, environmental modifications, simplifying tasks by ...

Discover whether it's possible to have mixed dementia, specifically a combination of Alzheimer's and Lewy body dementia. This ...

A landmark study examining over 3.4 million brain cells has revealed that Alzheimer’s disease progresses through two distinct ...

In mouse studies, elevating miR-195 ameliorates cognitive deficits, amyloid plaque burden, and tau hyper-phosphorylation. In addition, elevating miR-195 rescues AD-related lysosomal defects in ...

Nov. 19, 2024 — A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in ... Promising Daily Tablet ...